Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
10/21/2009 | CN101563324A Spiro-piperidine derivatives |
10/21/2009 | CN101563323A Spiro-piperidine derivatives |
10/21/2009 | CN101563319A Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
10/21/2009 | CN101560181A Preparation method of amlodipine free base |
10/21/2009 | CN101560018A Method for bioremediating waste water containing copper by common dayflower |
10/20/2009 | US7605272 N-{2-[2-(1H-indazol-3-yl)vinyl]-5-(4-methylpiperazin-1-ylmethyl)phenyl}-3-methylthiophene-2-carboxamide; type I insulin-like growth factor receptor inhibitors; anticarcinognenic agents; colon, pancreatic cancers; antitumor agents; hematopoietic tumors; industrial scale |
10/20/2009 | US7605176 β-ketoamide compounds with MCH antagonistic activity |
10/20/2009 | US7605111 Herbicides |
10/20/2009 | CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
10/20/2009 | CA2380986C Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
10/20/2009 | CA2245066C Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents |
10/15/2009 | WO2009126675A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10 |
10/15/2009 | WO2009126535A1 Compounds and compositions as modulators of gpr119 activity |
10/15/2009 | WO2009125606A1 Pai-1 inhibitor |
10/15/2009 | WO2009066072A3 Inhibitors of 17beta-hydroxysteroid dehydrogenase |
10/15/2009 | US20090258903 Aminoethane Sulfonamide Orexin Receptor Antagonists |
10/15/2009 | US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof |
10/15/2009 | US20090258897 Substituted benzimidazoles |
10/15/2009 | US20090258884 Substituted amides |
10/15/2009 | US20090258868 Heterocyclic aspartyl protease inhibitors |
10/15/2009 | US20090258061 Once-a-day replacement transdermal administration of fentanyl |
10/15/2009 | CA2720950A1 Compounds and compositions as modulators of gpr119 activity |
10/15/2009 | CA2720613A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10 |
10/15/2009 | CA2720096A1 Pai-1 inhibitor |
10/14/2009 | EP1893603B1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists |
10/14/2009 | EP1891009B1 A novel process for the preparation of lercanidipine |
10/14/2009 | EP1877367B1 Acetylene derivatives |
10/14/2009 | EP0970050B2 Process for the preparation of 5,6-dihydro-11h-dibenzo a,d cyclohept-11-enes |
10/14/2009 | CN101558040A Dihydropyridine derivatives useful as protein kinase inhibitors |
10/14/2009 | CN101555223A Pirlimycin intermediate and preparation method thereof |
10/14/2009 | CN100549012C Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors |
10/14/2009 | CN100548985C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B |
10/13/2009 | US7601874 Antiinflammatory agents; antiarthritic agents; brain disorders; multiple sclerosis; gout; inflammatory bowel disorders; gastrointestinal disorders; psoriasis; antiallergens; autoimmune disease |
10/13/2009 | US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
10/13/2009 | US7601844 Piperidinyl derivatives as modulators of chemokine receptor activity |
10/13/2009 | US7601843 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
10/13/2009 | US7601740 urea substituted piperidine derivatives; may confer antipsychotic and anti-dyskinetic efficacy in humans; use as novel therapeutics, sometimes in conjunction with other therapeutics, for Parkinson's Disease, related human neurodegenerative diseases, and psychosis |
10/13/2009 | CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
10/13/2009 | CA2429844C Mch antagonists and their use in the treatment of obesity |
10/08/2009 | WO2009121704A1 Method for making methylpentamethylene diamine and methylpiperidine |
10/08/2009 | WO2008112022A8 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
10/08/2009 | US20090253919 Chiral thiourea compounds and process for enantioselective reduction of ketones |
10/08/2009 | US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists |
10/08/2009 | US20090253748 Process for the preparation of pleuromutilins |
10/08/2009 | US20090253746 Synthesis and Preparations of Intermediates and New Polymorphs Thereof Useful For The Preparation Of Donepezil Hydrochlcoride |
10/08/2009 | US20090253745 Modulators of ocular oxidative stress |
10/08/2009 | US20090253743 Compositions of tolperisone |
10/08/2009 | US20090253742 Marasmius androsaceus l.es fr extract, piperidone derivative, and their use for the preparation of antihypertensives |
10/08/2009 | US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders |
10/08/2009 | US20090253700 N-'4-4(4-morpholinyl) phenyl!- '(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors |
10/08/2009 | US20090253670 nicotinic receptor modulators such as N-[3-(1H-pyrrol-1-yl)benzyl]-4-[(trifluoromethyl)thio]benzamide, useful for treating and preventing a condition or disorder affecting cognition, neurodegeneration and schizophrenia |
10/08/2009 | US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor |
10/08/2009 | US20090253653 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
10/07/2009 | EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure |
10/07/2009 | CN101553493A Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
10/07/2009 | CN101553256A Phenylpropionamide compounds and the use thereof |
10/06/2009 | US7598386 Sulphones which modulate the action of gamma-secretase |
10/06/2009 | US7598271 Crystalline paroxetine methane sulfonate |
10/06/2009 | US7598269 3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)-1-propanesulfonic acid; reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity |
10/06/2009 | US7598249 4-(3,4-dibromo-benzyl)-piperazine-1-carboxylic acid pyridin-3-ylamide; fatty acid amide hydrolase (FAAH) activity; anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders such as multiple sclerosis |
10/06/2009 | US7598012 Coloring compound and recording material using the same |
10/06/2009 | CA2301377C N-aroylphenylalanine derivatives |
10/01/2009 | WO2009119858A1 Benzene compound, and use thereof for medical purposes |
10/01/2009 | WO2009119700A1 Manufacturing method for a piperidine-3-ylcarbamate compound and optical resolution method therefor |
10/01/2009 | WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
10/01/2009 | WO2009118168A1 Substituted 4-aminocyclohexane derivatives |
10/01/2009 | WO2009117808A1 Inhibitors of histone deacetylase |
10/01/2009 | US20090247762 Method for producing thiocarbamate derivative |
10/01/2009 | US20090247584 Phenoxy-piperidines for the treatment of diseases such as schizophrenia and depression |
10/01/2009 | US20090247581 Organic Compounds |
10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
10/01/2009 | US20090247506 Antibacterial agents |
10/01/2009 | CA2719735A1 Substituted 4-aminocyclohexane derivatives |
10/01/2009 | CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
09/30/2009 | EP2105146A1 Nucleic-acid triggered release of molecules |
09/30/2009 | EP2104497A2 Urea and sulfamide derivatives as tafia inhibitors |
09/30/2009 | CN101544598A Diester sebacate (2,2,6,6-tetramethyl-4-hydroxypiperidine) nitroxide radical of high-efficiency polymerization inhibitor and production method thereof |
09/30/2009 | CN101544597A Method for preparing amlodipine |
09/30/2009 | CN101544596A Preferred crystal-form substance of nitrendipine and preparation method, pharmaceutical composition and application thereof |
09/30/2009 | CN101544595A Stearic acid 2,2,6,6-tetramethyl-4-piperidine ester of light stabilizer and production method thereof |
09/29/2009 | US7595399 Tyrosine derivatives |
09/29/2009 | US7595359 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays |
09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |
09/29/2009 | US7595343 Inhibitors of histone deacetylase |
09/29/2009 | US7595331 N-and O-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating CNS disorders therewith |
09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
09/29/2009 | US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
09/29/2009 | CA2484460C Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-yl]-1-piperidinyl]ethyl]-.alpha..alpha. dimethyl-benzeneacetic acid |
09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
09/29/2009 | CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors |
09/29/2009 | CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
09/24/2009 | WO2009117676A2 Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase |
09/24/2009 | WO2009116084A2 A method for the preparation of fentanyl |
09/24/2009 | WO2009116067A2 Novel derivatives of acyl cyanopyrrolidines |
09/24/2009 | WO2009115257A1 Substituted sulfonamide derivatives |
09/24/2009 | WO2009114950A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
09/24/2009 | US20090240056 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
09/24/2009 | US20090240053 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
09/24/2009 | US20090239910 Benzenesulfonamide Compounds and Their Use |
09/24/2009 | US20090239907 Methods and compositions for treating fish diseases |